Therapeutic management of chronic neuropathic pain: an examination of pharmacologic treatment (Q34595383)

3 August 2017

1 reference

title

Therapeutic management of chronic neuropathic pain: an examination of pharmacologic treatment (English)

1 reference

3 August 2017

0 references

0 references

chronic neuropathic pain

0 references

pain management

0 references

author name string

Athina Vadalouca

1

1 reference

3 August 2017

Ioanna Siafaka

2

1 reference

3 August 2017

Eriphylli Argyra

3

1 reference

3 August 2017

Evi Vrachnou

4

1 reference

3 August 2017

Eleni Moka

5

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

Annals of the New York Academy of Sciences

3 August 2017

published in

1 reference

3 August 2017

volume

1088

1 reference

3 August 2017

page(s)

164-186

1 reference

Mechanism-based pain diagnosis: issues for analgesic drug development

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Ion channels of nociception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Neuronal plasticity: increasing the gain in pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Pain genes?: natural variation and transgenic mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Towards a mechanism-based classification of pain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Neuropathic pain: aetiology, symptoms, mechanisms, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Diagnosis and Treatment of Neuropathic Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

EFNS guidelines on neuropathic pain assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Neuropathic pain: clinical characteristics and diagnostic workup

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

A comparison of the SF-36 and Nottingham Health Profile in patients with chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Peripheral neuropathic pain--a multidimensional burden for patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Incidence of central post-stroke pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Evidence-based pharmacological treatment of neuropathic pain syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Pain and dysesthesia in patients with spinal cord injury: A postal survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Utilization patterns of tricyclic antidepressants in a multidisciplinary pain clinic: a survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

A treatment algorithm for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Gabapentin for the treatment of pain in guillain-barré syndrome: a double-blinded, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379]

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

The effect of opioids on phantom limb pain and cortical reorganization

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Oral opioid therapy for chronic peripheral and central neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Morphine, gabapentin, or their combination for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Opioid Therapy for Chronic Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Mechanistic Stratification of Antineuralgic Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

A systematic review of antidepressants in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Lamotrigine in spinal cord injury pain: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Newer antiepileptic drugs in bipolar disorder: rationale for use and role in therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Venlafaxine in neuropathic pain following treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Effectiveness of tizanidine in neuropathic pain: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

The NMDA-receptor antagonist ketamine abolishes neuropathic pain after epidural administration in a clinical case

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

Transcutaneous electrostimulation: emerging treatment for diabetic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1366.016

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1366.016

1 reference

3 August 2017

1 reference